I hope my posts didn't come across as being concerned. That wasn't my intent.
It is always good to research and keep across competitors playing in the same space.
I shared this material for comparison and educational purposes.
It would appear that BriaCell is months ahead of IMU's CHECKvacc trial, so their experience with their FDA submissions will provide us with some insights.
It also gives us some insight into other platform and partnering arrangements.
I found the information quite informative, so hopefully others may too.
GLTAHs
Ann: FIRST PATIENT DOSED IN PHASE I CLINICAL TRIAL OF CHECKVACC, page-145
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.2¢ |
Change
-0.003(3.53%) |
Mkt cap ! $600.2M | |||
| Open | High | Low | Value | Volume |
| 8.5¢ | 8.6¢ | 8.2¢ | $1.246M | 14.84M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 446526 | 8.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.3¢ | 535664 | 2 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
8.2¢ |
Change
-0.003 ( 2.38 %) |
||||
| Open | High | Low | Volume | ||
| 8.6¢ | 8.6¢ | 8.2¢ | 4518456 | ||
| Last updated 15.57pm 03/05/2024 ? | |||||
| IMU (ASX) Chart |